A detailed history of Commonwealth Equity Services, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 2,309 shares of NUVL stock, worth $194,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,309
Previous 4,404 47.57%
Holding current value
$194,463
Previous $334,000 29.34%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$67.44 - $112.17 $141,286 - $234,996
-2,095 Reduced 47.57%
2,309 $236,000
Q2 2024

Jul 31, 2024

BUY
$62.76 - $81.61 $105,813 - $137,594
1,686 Added 62.03%
4,404 $334,000
Q1 2024

Apr 29, 2024

BUY
$72.35 - $88.99 $196,647 - $241,874
2,718 New
2,718 $204,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.62B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.